“Interventional radiology has always been characterised by its innovative spirit. We are now seeing progress with new procedures being developed to create percutaneous arteriovenous fistulae. I am impatiently awaiting the results of the NEAT (Novel endovascular access trial) study,” Gireesh Mukund Warawdekar, consultant interventional radiologist at several leading hospitals in Mumbai, India, and 2014–16 president of the Indian Society of Vascular and Interventional Radiology (ISVIR), tells Interventional News.
“War (as in turf war) is an emotional word because in wars, people get hurt. I believe we truly care about the patients we serve and the last thing we want is for patients to get hurt. […] By and large, we have found that approaching role extension issues through discussion is preferable to confrontation,” Gregory John Slater, president, The Royal Australian and New Zealand College of Radiologists (RANZCR), tells Interventional News. Slater is a radiologist at Queensland X-Ray, Brisbane, Australia and a visiting medical officer at several private hospitals. He enjoys the outdoors, and like any true blue Aussie, loves throwing a shrimp on the barbie.
QT Vascular has announced that it has entered into an asset purchase option agreement with Medtronic, for the acquisition of the non-drug coated Chocolate PTA.
Peripheral artery disease patients who were treated with an anti-inflammatory steroid injected directly into the tissue surrounding their leg artery showed a significant reduction in inflammatory biomarkers.
The Canadian Interventional Radiology Association (CIRA) Board of Directors has announced the appointment of Daniel Lapointe as CIRA’s new executive director on the association’s website.
Two new sub-analyses from the IN.PACT Global Study of the IN.PACT Admiral in patients with peripheral artery disease have been reported at the annual 2017 Charing Cross Symposium (CX) in London, UK, one of the world’s largest educational meetings specialising in vascular and endovascular disease management.
Positive results from the RANGER SFA trial for Boston Scientific’s Ranger paclitaxel-coated percutaneous transluminal angioplasty (PTA) balloon catheter have been presented at the 2017 CX Symposium in London, UK. Data demonstrated that the drug-coated balloon (DCB) exhibited both a high rate of primary patency and freedom from target lesion revascularisation at 12 months, reducing the need for re-interventions to re-establish flow in previously blocked blood vessels.
BD (Becton, Dickinson and company) has definitively agreed to acquire Bard for US$317 per common share in cash and stock, for a total consideration of US$24 billion.
Getinge is proud to announce the launch of the Advanta V12 32mm length balloon expandable covered stent at the Charing Cross International Conference. This is a much needed addition to the Advanta V12 product offering and will allow clinicians additional treatment options for optimal patient outcomes, a press release from the company says.
Merit has showcased a new radial compression product, Preludesync, on its website.
Lombard Medical’s portfolio of endovascular stent graft systems, Altura and Aorfix, were featured in scientific presentations at the 39th annual Charing Cross International Symposium (CX; 25–28 April, London, UK).
Significant success has been achieved in treating complex proximal aneurysms using a combination of fenestrated and branched graft devices, based on a report of prospectively studied patients with complex aortic aneurysm in the May edition of the Journal of Vascular Surgery.
Howard Rosen has joined Intact Vascular’s executive management team as vice president of marketing and business development. In this position, Rosen will lead the company’s efforts to prepare for commercialisation of its Tack Endovascular System for the repair of dissections following peripheral artery angioplasty.
Contego Medical has announced that it has received CE mark for its Vanguard IEP peripheral balloon angioplasty system with integrated embolic protection. The company intends to launch the Vanguard IEP system in Europe to endovascular specialists performing lower limb angioplasty procedures.
Twelve posters selected for presentation out of 68 posters displayed were carefully reviewed by the CX Abstract Board, who decided to award their prize of a free CX 2018 registration to (San Donato Milanese, Italy) for her poster, “Study and patient specific prediction of the fatigue behaviour of peripheral nitinol stent of the superficial femoral arteries through mathematical modelling”. One of four peripheral arterial posters, Mazzaccaro’s took an innovative approach to the subject at hand.
Cookies Sociales
Son esos botones que permiten compartir el contenido del sitio web en sus redes sociales (Facebook, Twitter y Linkedin, previo tu consentimiento y login) a través de sistemas totalmente gestionados por dichas redes sociales, así como los recursos (pej. videos) y material que se encuentra en nuestra web, y que de igual manera se presta y gestiona completamente por un tercero.
Si no acepta estas cookies, no podrá compartir nuestro contenido a través de los botones, y en su caso, no podrás visualizar el contenido de terceros que hayamos incrustado en el sitio.
No las utilizamos